Chimeric autoantibody receptor cell therapy for the treatment of membranous nephropathy: The authors reply
Standard
Chimeric autoantibody receptor cell therapy for the treatment of membranous nephropathy: The authors reply. / Fehse, Boris; Tomas, Nicola M.
In: KIDNEY INT, Vol. 105, No. 6, 06.2024, p. 1320-1321.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research
Harvard
Fehse, B & Tomas, NM 2024, 'Chimeric autoantibody receptor cell therapy for the treatment of membranous nephropathy: The authors reply', KIDNEY INT, vol. 105, no. 6, pp. 1320-1321. https://doi.org/10.1016/j.kint.2024.03.006
APA
Fehse, B., & Tomas, N. M. (2024). Chimeric autoantibody receptor cell therapy for the treatment of membranous nephropathy: The authors reply. KIDNEY INT, 105(6), 1320-1321. https://doi.org/10.1016/j.kint.2024.03.006
Vancouver
Fehse B, Tomas NM. Chimeric autoantibody receptor cell therapy for the treatment of membranous nephropathy: The authors reply. KIDNEY INT. 2024 Jun;105(6):1320-1321. https://doi.org/10.1016/j.kint.2024.03.006
Bibtex
@article{b0a930516f13419b85e3c1a5ce4a7803,
title = "Chimeric autoantibody receptor cell therapy for the treatment of membranous nephropathy: The authors reply",
keywords = "Humans",
author = "Boris Fehse and Tomas, {Nicola M}",
year = "2024",
month = jun,
doi = "10.1016/j.kint.2024.03.006",
language = "English",
volume = "105",
pages = "1320--1321",
journal = "KIDNEY INT",
issn = "0085-2538",
publisher = "NATURE PUBLISHING GROUP",
number = "6",
}
RIS
TY - JOUR
T1 - Chimeric autoantibody receptor cell therapy for the treatment of membranous nephropathy: The authors reply
AU - Fehse, Boris
AU - Tomas, Nicola M
PY - 2024/6
Y1 - 2024/6
KW - Humans
U2 - 10.1016/j.kint.2024.03.006
DO - 10.1016/j.kint.2024.03.006
M3 - SCORING: Journal article
C2 - 38777406
VL - 105
SP - 1320
EP - 1321
JO - KIDNEY INT
JF - KIDNEY INT
SN - 0085-2538
IS - 6
ER -
